These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22729760)

  • 1. Is cyclophosphamide effective in patients with IgM-positive minimal change disease?
    Geier P; Roushdi A; Skálová S; Vethamuthu J; Weiler G; Feber J
    Pediatr Nephrol; 2012 Dec; 27(12):2227-31. PubMed ID: 22729760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.
    Swartz SJ; Eldin KW; Hicks MJ; Feig DI
    Pediatr Nephrol; 2009 Jun; 24(6):1187-92. PubMed ID: 19219463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
    Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
    J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook].
    Berkane M; Adarmouch L; Amine M; Bourrahouat A; Ait Sab I; Sbihi M
    Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome.
    Bircan Z; Kara B
    Pediatr Int; 2003 Feb; 45(1):65-7. PubMed ID: 12654072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
    Trachtman H; Laskowski J; Lee C; Renner B; Feemster A; Parikh S; Panzer SE; Zhong W; Cravedi P; Cantarelli C; Kulik L; You Z; Satchell S; Rovin B; Liu F; Kalled SL; Holers VM; Jalal D; Thurman JM
    Am J Physiol Renal Physiol; 2021 Oct; 321(4):F505-F516. PubMed ID: 34459222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
    Fujinaga S; Hirano D; Nishino T; Umeda C; Watanabe Y; Nakagawa M
    Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM; Ezzat DA; Doudar NA; Adel M
    Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal biopsy in children with steroid-dependent nephrotic syndrome.
    Skalova S; Podhola M; Geier P; Tichy T
    Bratisl Lek Listy; 2009; 110(10):647-9. PubMed ID: 20017458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
    Watanabe Y; Fujinaga S; Endo A; Endo S; Nakagawa M; Sakuraya K
    Pediatr Nephrol; 2020 Dec; 35(12):2377-2381. PubMed ID: 32964318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of trace deposition of immunoglobulin M in glomerular mesangium in children with minimal change nephrotic syndrome].
    Li ZH; Xia TH; Duan CR; Wu TH; Xun M; Yin Y; Ding YF; Zhang Y; Zhang L
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Mar; 17(3):222-6. PubMed ID: 25815488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
    Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
    Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous pulse cyclophosphamide--is it effective in children with steroid-resistant nephrotic syndrome?
    Alshaya HO; Al-Maghrabi JA; Kari JA
    Pediatr Nephrol; 2003 Nov; 18(11):1143-6. PubMed ID: 13680329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of low-dose rituximab in minimal change disease and prevention of relapse.
    Zhang J; Zhao H; Li X; Qian R; Gao P; Lu S; Ma Z
    BMC Nephrol; 2023 Apr; 24(1):112. PubMed ID: 37101300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in adult patients with immunosuppressive-dependent minimal change disease.
    Hoxha E; Stahl RA; Harendza S
    Clin Nephrol; 2011 Aug; 76(2):151-8. PubMed ID: 21762648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits.
    Cavallo T; Johnson MP
    Nephron; 1981; 27(6):281-4. PubMed ID: 7266716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.